These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 1628128
1. Slow response to induction chemotherapy is an indicator of poor survival after bone marrow transplantation for acute lymphoblastic leukemia. The Leukemia Working Party of the European Group of Bone Marrow Transplantation (EBMT). Niederwieser D, Granena A, Hermans J, Kolb HJ, Zwaan F, Gratwohl A. Bone Marrow Transplant; 1992 Jun; 9(6):439-43. PubMed ID: 1628128 [Abstract] [Full Text] [Related]
2. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC. Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048 [Abstract] [Full Text] [Related]
3. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F. J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124 [Abstract] [Full Text] [Related]
4. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E. Bone Marrow Transplant; 1996 Jul 01; 18(1):111-7. PubMed ID: 8832003 [Abstract] [Full Text] [Related]
5. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Ringdén O, Labopin M, Frassoni F, Sanz G, Demeocq F, Prentice H, Cahn JY, Barbui T, Meloni G, Schaefer U, Reiffers J, Gorin N. Bone Marrow Transplant; 1999 Aug 01; 24(4):389-96. PubMed ID: 10467328 [Abstract] [Full Text] [Related]
6. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Runde V, de Witte T, Arnold R, Gratwohl A, Hermans J, van Biezen A, Niederwieser D, Labopin M, Walter-Noel MP, Bacigalupo A, Jacobsen N, Ljungman P, Carreras E, Kolb HJ, Aul C, Apperley J. Bone Marrow Transplant; 1998 Feb 01; 21(3):255-61. PubMed ID: 9489648 [Abstract] [Full Text] [Related]
7. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)]. Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA. Sangre (Barc); 1996 Apr 01; 41(2):101-8. PubMed ID: 9045349 [Abstract] [Full Text] [Related]
9. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation. Gratwohl A, Hermans J, Niederwieser D, Frassoni F, Arcese W, Gahrton G, Bandini G, Carreras E, Vernant JP, Bosi A. Bone Marrow Transplant; 1993 Nov 01; 12(5):509-16. PubMed ID: 8298562 [Abstract] [Full Text] [Related]
10. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study. Ringdén O, Labopin M, Gluckman E, Hows JM, Bradley BA, Kolb HJ, Fouillard L, Jacobsen N, Vernant JP, Witz F, Harousseau JL, Gorin NC. Bone Marrow Transplant; 1997 May 01; 19(10):963-8. PubMed ID: 9169639 [Abstract] [Full Text] [Related]
11. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children. Hoogerbrugge PM, Gerritsen EJ, vd Does-van den Berg A, vd Berg H, Zwinderman AH, Hermans J, Vossen JM. Bone Marrow Transplant; 1995 Feb 01; 15(2):255-9. PubMed ID: 7773215 [Abstract] [Full Text] [Related]
12. Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Frassoni F, Labopin M, Gluckman E, Prentice HG, Gahrton G, Mandelli F, Carella M, Herve P, Gratwohl A, Goldman J. Leukemia; 1994 Jun 01; 8(6):924-8. PubMed ID: 8207985 [Abstract] [Full Text] [Related]
13. European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Working Party on Acute Leukemia of the European Cooperative Group for Bone Marrow Transplantation (EMBT). Mandelli F, Labopin M, Granena A, Iriondo A, Prentice G, Bacigalupo A, Sierra J, Meloni G, Frassoni F, Goldman J. Bone Marrow Transplant; 1994 Aug 01; 14(2):293-8. PubMed ID: 7994245 [Abstract] [Full Text] [Related]
14. Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis. Reiffers J, Labopin M, Sanz M, Korbling M, Blaise D, De La Rubia J, Gorin NC. Bone Marrow Transplant; 2000 Jun 01; 25(11):1115-9. PubMed ID: 10849522 [Abstract] [Full Text] [Related]
15. Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission. Vey N, Blaise D, Stoppa AM, Bouabdallah R, Lafage M, Sainty D, Cowen D, Viens P, Lepeu G, Blanc AP. Bone Marrow Transplant; 1994 Sep 01; 14(3):383-8. PubMed ID: 7994259 [Abstract] [Full Text] [Related]
16. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission. Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V, Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Haematologica; 2008 Jun 01; 93(6):834-41. PubMed ID: 18469352 [Abstract] [Full Text] [Related]
17. Allogeneic bone marrow transplantation for leukemia in Europe: regional differences. Report from the Leukemia Working party of the European Group for Bone Marrow Transplantation. Gratwohl A, Hermans J, Barrett AJ, Ernst P, Frassoni F, Gahrton G, Granena A, Kolb HJ, Prentice HG, Vernant JP. Bone Marrow Transplant; 1990 Mar 01; 5(3):159-65. PubMed ID: 2331536 [Abstract] [Full Text] [Related]
18. [Comparison of long-term survival between bone marrow transplantation and maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission]. Suzuki N, Koike T, Furukawa T, Niwano H, Maruyama S, Narita M, Takizawa J, Sato N, Hashimoto S, Nikkuni K, Toba K, Kishi K, Takahashi M, Aizawa Y, Shibata A. Rinsho Ketsueki; 1997 Feb 01; 38(2):95-9. PubMed ID: 9059062 [Abstract] [Full Text] [Related]
19. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Kishi K, Takahashi S, Gondo H, Shiobara S, Kanamaru A, Kato S, Hirabayashi N, Moriyama Y, Harada M, Asano S, Hara H, Shibata A. Bone Marrow Transplant; 1997 Mar 01; 19(5):461-6. PubMed ID: 9052912 [Abstract] [Full Text] [Related]
20. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941. Gaynon PS, Harris RE, Altman AJ, Bostrom BC, Breneman JC, Hawks R, Steele D, Zipf T, Stram DO, Villaluna D, Trigg ME. J Clin Oncol; 2006 Jul 01; 24(19):3150-6. PubMed ID: 16717292 [Abstract] [Full Text] [Related] Page: [Next] [New Search]